XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.4
10. STOCK-BASED COMPENSATION
9 Months Ended
Dec. 31, 2020
STOCK-BASED COMPENSATION  
NOTE 10 - STOCK-BASED COMPENSATION

 

NOTE 10—STOCK-BASED COMPENSATION

 

As of December 31, 2020, 1,576,722 shares of common stock were available for grant under the Company’s 2016 Equity Incentive Plan.

 

The following table summarizes the Company’s stock option activities for the nine months ended December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Number of Shares

 

Average

 

Weighted

 

 

 

 

 

 

Shares

 

Underlying

 

Remaining

 

Average

 

 

 

 

 

 

Available for

 

Options

 

Contractual

 

Exercise

 

Intrinsic

 

 

    

Grant

    

Outstanding

    

Life (Years)

    

Price

    

Value

 

Balance at March 31, 2020

 

2,522,314

 

8,135,791

 

 

 

$

6.17

 

 

 

 

Granted

 

(989,842)

 

989,842

 

 

 

$

6.14

 

 

 

 

Exercised

 

 —

 

(443,190)

 

 

 

$

5.94

 

$

583,645

 

Forfeited

 

44,250

 

(161,833)

 

 

 

$

7.01

 

 

 

 

Balance at December 31, 2020

 

1,576,722

 

8,520,610

 

5.57

 

$

6.17

 

 

 

 

Options vested and exercisable

 

 

 

5,497,662

 

4.02

 

$

5.70

 

$

9,735,923

 

Options vested and expected to vest

 

 

 

8,440,795

 

5.54

 

$

6.16

 

$

11,522,386

 

 

The weighted average fair value per underlying share of options granted during the three months ended December 31, 2020 and 2019 was $2.51 and $2.66, respectively, and $2.39 and $2.84 for the nine months ended December 31, 2020 and 2019, respectively.

 

Options outstanding by exercise price at December 31, 2020 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

 

Shares

 

Weighted

 

Weighted Average

 

 

 

Weighted

 

 

 

 

 

 

Underlying

 

Average

 

Remaining

 

Number

 

Average

 

 

 

 

 

 

Options

 

Exercise

 

Contractual

 

Vested and

 

Exercise

 

Exercise Price

    

Outstanding

    

Price

    

Life (Years)

    

Exercisable

    

Price

 

$

3.40

-

4.81

 

888,007

 

$

4.06

 

3.32

 

888,007

 

$

4.06

 

$

4.90

-

4.99

 

1,255,826

 

$

4.97

 

4.48

 

1,255,826

 

$

4.97

 

$

5.13

-

5.59

 

910,509

 

$

5.32

 

3.68

 

910,509

 

$

5.32

 

$

5.69

-

5.83

 

854,567

 

$

5.81

 

7.36

 

270,874

 

$

5.76

 

$

5.91

-

6.45

 

933,860

 

$

6.17

 

6.18

 

568,329

 

$

6.20

 

$

6.54

-

6.70

 

1,100,140

 

$

6.65

 

5.15

 

555,193

 

$

6.60

 

$

6.86

-

7.26

 

1,042,797

 

$

7.08

 

5.55

 

563,773

 

$

6.95

 

$

7.40

-

8.09

 

812,431

 

$

7.79

 

8.27

 

330,598

 

$

7.79

 

$

8.30

 

 

 

613,893

 

$

8.30

 

8.58

 

45,973

 

$

8.30

 

$

9.20

 

 

 

108,580

 

$

9.20

 

0.08

 

108,580

 

$

9.20

 

 

 

 

 

 

8,520,610

 

$

6.17

 

5.57

 

5,497,662

 

$

5.70

 

 

The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

 

2020

 

2019

 

2020

 

2019

    

 

 

 

 

 

 

(In Thousands)

 

 

 

 

Cost of revenues

 

$

88

 

$

77

 

$

260

 

$

184

 

Research and development

 

 

343

 

 

347

 

 

1,109

 

 

1,143

 

Selling, general and administrative

 

 

262

 

 

205

 

 

732

 

 

595

 

Total

 

$

693

 

$

629

 

$

2,101

 

$

1,922

 

 

As stock-based compensation expense recognized in the Condensed Consolidated Statement of Operations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures in accordance with authoritative guidance.  The Company estimates forfeitures at the time of grant and revises the original estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

No tax benefit related to stock-based compensation was recognized in the nine months ended December 31, 2020 due to a full valuation allowance. There were no windfall tax benefits realized from exercised stock options in either of these periods. Compensation cost capitalized within inventory at December 31, 2020 was immaterial. As of December 31, 2020, the Company’s total unrecognized compensation cost was $5.2 million, which will be recognized over a weighted average period of 2.09 years.  The Company calculated the fair value of stock-based awards in the periods presented using the Black-Scholes option pricing model and the following weighted average assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

 

2020

 

2019

 

 

 

2020

 

 

 

 

2019

 

    

 

 

 

 

 

 

Stock Option Plans:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

 

0.38

%

 

 

 

1.66

%

 

0.22

-

0.38

%

 

1.66

-

2.30

%

 

Expected life (in years)

 

 

 

5.00

 

 

 

 

5.00

 

 

 

 

5.00

 

 

 

 

5.00

 

 

Volatility

 

 

 

47.1

%

 

 

 

36.5

%

 

41.9

-

47.1

%

 

36.5

-

37.3

%

 

Dividend yield

 

 

 

 —

%

 

 

 

 —

%

 

 

 

 —

%

 

 

 

 —

%

 

Employee Stock Purchase Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

 

0.12

%

 

 

 

1.58

%

 

0.12

-

0.15

%

 

1.58

-

2.43

%

 

Expected life (in years)

 

 

 

0.50

 

 

 

 

0.50

 

 

 

 

0.50

 

 

 

 

0.50

 

 

Volatility

 

 

 

68.6

%

 

 

 

33.5

%

 

67.1

-

68.6

%

 

33.5

-

43.1

%

 

Dividend yield

 

 

 

 —

%

 

 

 

 —

%

 

 

 

 —

%

 

 

 

 —

%